BioMarin Pharmaceutical
Insider trading & Transactions

Last updated: 26 Jan 2017

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	26 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	5,000	$17.33	$86,650
Sale	26 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	5,000	$17.33	$86,650
Option	25 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	5,000	$17.33	$86,650
Sale	25 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	5,000	$17.33	$86,650
Option	25 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	5,000	$17.33	$86,650
Sale	11 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Option	11 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Option	11 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	4,000	$17.33	$69,320
Option	10 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	4,000	$17.33	$69,320
Option	10 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Sale	10 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Sale	9 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Option	9 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Option	9 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	4,000	$17.33	$69,320
Sale	9 Jan 2017	SPIEGELMAN DANIEL K officer: EVP, Chief Financial Officer officer: EVP, Chief Financial O..	Common Stock	5,000	$90	$450,000
Sale	6 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Option	6 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	4,000	$17.33	$69,320
Option	6 Jan 2017	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Option	30 Dec 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	4,000	$17.33	$69,320
Sale	30 Dec 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Option	30 Dec 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Option	29 Dec 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Option	29 Dec 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	4,000	$17.33	$69,320
Sale	29 Dec 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$17.33	$69,320
Option	25 Nov 2016	FUCHS HENRY J officer: President, Worldwide R&D officer: President, Worldwide R&D	Stock Option (Right to buy Common Stock)	15,000	$26.49	$397,350
Sale	25 Nov 2016	FUCHS HENRY J officer: President, Worldwide R&D officer: President, Worldwide R&D	Common Stock	15,000	$26.49	$397,350
Option	25 Nov 2016	FUCHS HENRY J officer: President, Worldwide R&D officer: President, Worldwide R&D	Common Stock	15,000	$26.49	$397,350
Option	22 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	69,743	$85.69	$5,976,487
Sale	22 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	69,743	$85.69	$5,976,487
Option	22 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	69,743	$85.69	$5,976,487
Option	21 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	69,744	$26.49	$1,847,519
Sale	21 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	69,744	$26.49	$1,847,519
Option	21 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	69,744	$26.49	$1,847,519
Sale	18 Nov 2016	DAVIS GEORGE ERIC officer: EVP, General Counsel officer: EVP, General Counsel	Common Stock	5,000	$38.59	$192,950
Option	18 Nov 2016	DAVIS GEORGE ERIC officer: EVP, General Counsel officer: EVP, General Counsel	Common Stock	5,000	$38.59	$192,950
Option	18 Nov 2016	DAVIS GEORGE ERIC officer: EVP, General Counsel officer: EVP, General Counsel	Stock Option (Right to buy) Common Stock	5,000	$38.59	$192,950
Option	16 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	41,670	$17.54	$730,892
Sale	16 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	41,670	$17.54	$730,892
Option	16 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	41,670	$17.54	$730,892
Option	9 Nov 2016	LAWLIS V BRYAN director director	Common Stock	7,500	$17.33	$129,975
Option	9 Nov 2016	LAWLIS V BRYAN director director	Stock Option (Right to buy) Common Stock	7,500	$17.33	$129,975
Sale	9 Nov 2016	LAWLIS V BRYAN director director	Common Stock	7,500	$17.33	$129,975
Sale	9 Nov 2016	SPIEGELMAN DANIEL K officer: EVP, Chief Financial Officer officer: EVP, Chief Financial O..	Common Stock	20,000	$90.61	$1,812,200
Option	8 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	70,000	$21.51	$1,505,700
Sale	8 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	70,000	$21.51	$1,505,700
Option	8 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	70,000	$21.51	$1,505,700
Option	7 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	70,000	$21.51	$1,505,700
Option	7 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy Common Stock)	70,000	$21.51	$1,505,700
Sale	7 Nov 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	70,000	$21.51	$1,505,700
Option	28 Oct 2016	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	60,000	$14.39	$863,400

Showing 750 to 800 of 2449 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

BioMarin Pharmaceutical Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

BioMarin Pharmaceutical
Insider trading & Transactions